Maternal immunization with pneumococcal polysaccharide vaccine in the Philippines.
A randomized, controlled study was conducted to evaluate the immunogenicity and reactogenicity of the 23-valent pneumococcal (Pnc) polysaccharide (PS) vaccine among pregnant women and to ascertain the transfer of anti-Pnc antibody (Ab) from mother to infant. One hundred and sixty women received either one dose of Pnc PS vaccine, Haemophilus influenzae type b conjugate vaccine and tetanus toxoid (TT) (Pnc vaccine group, N=106) or TT only (control group, N=54). Sera were obtained from all mothers prior to vaccination and 4 weeks after from the vaccinated group. Cord blood was obtained in 75% of deliveries. Anti-Pnc Ab for serotypes 1, 5, 6B, 14, 18C and 19F was determined using enzyme immunoassay. The Pnc vaccine and control groups were comparable in terms of age, parity, gravidity, prior doses of TT, and pre-vaccination geometric mean concentration (GMC in microg/ml) of anti-Pnc Ab. Between 66 and 87% of the mothers had type-specific Ab prior to vaccination. There was a significant rise in anti-Pnc Ab (varying from 3.3- to 9.1-fold for the individual serotypes) between the pre and post-vaccination samples. Adverse reactions were mild and required no treatment. The level of anti-Pnc Ab in cord blood was significantly lower in the control group compared to the Pnc vaccine group. Vaccination of pregnant women with Pnc Ps vaccine induces good immune response and Ab can be transferred to their infants via cord blood thus providing enhanced protection.
Quiambao
B P
BP
Research Institute for Tropical Medicine, Alabang, Muntinlupa, Metro Manila 1781, Philippines. bquiambao@ritm.gov.ph
Nohynek
H
H
Käyhty
H
H
Ollgren
J
J
Gozum
L
L
Gepanayao
C P
CP
Soriano
V
V
Mäkela
P H
PH
D000328:Adult; D000907:Antibodies, Bacterial / Q000032:analysis / Q000096:biosynthesis; D005260:Female; D005312:Fetal Blood / Q000276:immunology; D006801:Humans; D017589:Immunization Programs; D007231:Infant, Newborn; D010679:Philippines; D022242:Pneumococcal Vaccines / Q000009:adverse effects / Q000276:immunology*; D011247:Pregnancy; D011263:Pregnancy Trimester, Third / Q000276:immunology*; D012703:Serotyping; D013296:Streptococcus pneumoniae / Q000276:immunology
D000907:Antibodies, Bacterial; D022242:Pneumococcal Vaccines